Even though his title is VP Corp Dev, reading the PR it appears his role is IR & raising capital. "Andrew is a seasoned veteran that understands the important roles of Investor Relations, banking relationships and raising capital," said Michael T. Redman, president and chief executive officer of Oncolix. So its not far fetched to believe he's not clued into every nuance about the company. Considering its only one week, I wouldnt get too concerned These are fair questions being asked. Perhaps better directed to the CEO